Optimizing Weblinks Used in Digital Vaccination Invitations to Raise Trust and Booking Intention: Online Experiment 1
2 other identifiers
interventional
1,226
1 country
1
Brief Summary
This study investigates whether the design of weblinks in digital vaccination invitations affects how much people trust the message and their willingness to book an appointment. Researchers compare a standard third-party weblink used by the NHS ("accurx.thirdparty.nhs.uk/r/aafwaczmd5") with an improved, more transparent weblink (https://vaccine-booking.nhs.uk). The study tests the hypothesis that the improved link will be perceived as more trustworthy and easier to read than the standard link. Further, the study tests whether participants would be more likely to correctly identify the sender and would be more willing to book a vaccine when shown the improved link. To test these effects, the investigators planned to conduct a study with 600 participants from the United Kingdom and 600 from the United States. Participants will be randomly assigned to view one of the two hypothetical email versions. UK participants will see an email that appears to be from the NHS. US participants will see an email from a fictitious pharmacy (Pharma-US).This research aims to provide evidence on how to design more trustworthy digital health communications when recipients are asked to click a weblink.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 10, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 10, 2022
CompletedFirst Submitted
Initial submission to the registry
March 24, 2026
CompletedFirst Posted
Study publicly available on registry
April 8, 2026
CompletedApril 8, 2026
March 1, 2026
7 days
March 24, 2026
March 31, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Perceived Trustworthiness
Participants rated the perceived trustworthiness of the vaccination invitation email on a 5-point Likert scale, where 1 represents "Very suspicious" and 5 represents "Very trustworthy"
Immediately after intervention
Booking Intention
Participants rated their likelihood of booking a vaccine appointment based on the email invitation using a 5-point Likert scale ranging from 1 ("Very unlikely") to 5 ("Very likely")
Immediately after intervention
Secondary Outcomes (2)
Ease of reading
Immediately after intervention
Host Identification
Immediately after intervention
Study Arms (2)
Control
NO INTERVENTIONParticipants were assigned to view a vaccination invitation email containing the control weblink (UK participants: accurx.thirdparty.nhs.uk/r/aafwaczmd5; US participants: accurx.thirdparty.pharma-us.com/r/aafwaczmd5
Clear Link
EXPERIMENTALParticipants were assigned to view an email containing an improved version of the link (UK participants: https://vaccine-booking.nhs.uk; US participants: https://vaccine-booking.pharma-us.com)
Interventions
The intervention involves presenting a digital COVID-19 booster vaccination invitation via email. Participants are randomly allocated to view one of two versions of the invitation to evaluate the impact of the weblink design on trust and behaviour. To ensure local relevance, the email content is adapted based on the participant's country of residence; participants in the United Kingdom see invitations sent from the NHS, while those in the United States see invitations from Pharma-US
Eligibility Criteria
You may qualify if:
- Residency: Must be a resident of either the United Kingdom or the United States
You may not qualify if:
- Attention Failure: Participants who failed the designated attention check included within the survey will be excluded from the analysis
- Speeding: Participants who completed the study "too fast"-indicating a lack of meaningful engagement with the experimental stimuli-were filtered out
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Essexlead
- University of Southern Californiacollaborator
- Department of Health and Social Care, UKcollaborator
- Kingston Universitycollaborator
Study Sites (1)
University of Essex
Colchester, Essex, CO4 3SQ, United Kingdom
Related Links
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- This is a double-blind study in which participants were unaware of the specific experimental condition to which they had been assigned. Participants were randomly allocated to view only one of two possible versions of a hypothetical vaccination invitation email and were not informed of the existence or nature of the alternative stimulus. This ensures that their evaluations of trustworthiness, fluency, and booking intentions were not influenced by a direct comparison between the two link designs. As the study was conducted as an online survey via a fully automated platform, there is no direct interaction between the investigators and the participants during the intervention.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Psychology
Study Record Dates
First Submitted
March 24, 2026
First Posted
April 8, 2026
Study Start
January 3, 2022
Primary Completion
January 10, 2022
Study Completion
January 10, 2022
Last Updated
April 8, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- The data and the study protocol were shared while the main scientific output was under review for publication. After acceptance for publication, all content will be made publicly available.
- Access Criteria
- The data and study protocol will be freely accessible to the public after the main scientific output is accepted for publication.
Anonymised study data is shared on the Open Science Framework.